PARIS, July 22, 2026, 12:13 CEST — Trading was active on Euronext while the NYSE main session had not yet begun.
- MANE secured exclusive worldwide rights to manufacture and market ViaLeaf Reb M.
- Initial calculations indicate annual sugar-equivalent sweetness could exceed 142,500 tonnes.
- The read-through referred to is Ingredion NYSE:INGR, not international sugar producers.
MANE has obtained exclusive worldwide rights to manufacture and sell ViaLeaf Reb M. The agreement establishes a unified competitor in the premium stevia sector.
The concern for investors is not the demand for sugar, but rather pricing for specialty sweeteners and their share in formulations.
Ingredion NYSE:INGR serves as the nearest public peer thanks to its PureCircle division. PureCircle manufactures Reb M via three different methods.
| Scale comparison | Reported figure |
|---|---|
| Latest announced annual capacity for ViaLeaf | More than 500 tonnes |
| Claimed sweetness compared to sucrose | 285 times |
| Estimated annual sweetness equivalent output | More than 142,500 tonnes |
| USDA world centrifugal sugar use for 2026/27 | 179.991 million tonnes |
| Estimated implied global share | About 0.08% |
This is an initial estimate based on capacity and sweetness levels reported by the company. It does not project actual physical sugar substitution.
This represents commercial-scale production for a high-intensity ingredient, but it is not significant for global sugar balances.
Sweetness-equivalent does not reflect physical displacement. Texture, bulk and flavour of a product restrict how much can really be substituted.
The smaller market may still impact margins. Here, ingredient economics carry greater importance than commodity volume.
Arzeda reports that ViaLeaf requires 48% less material than Reb A for the same 8% sugar equivalence. The company estimates the replacement cost at about two-thirds that of sugar. These figures are based on Arzeda’s own data.
Guus Gerritsen, MANE’s U.S. ingredients director, commented that Reb M has potential to extend “far beyond only premium products.” He mentioned an “active pipeline of customers,” without specifying any names. foodingredientsfirst.com
The group’s chief executive, Samantha Mane, described the offer as offering “competitive economics.” The statement did not disclose a license price, volume terms or a revenue goal. PR Newswire
MANE posted revenue of €2.012 billion for 2025. The agreement brings ViaLeaf into MANE’s worldwide commercial network.
Ingredion counters with a wide product range. PureCircle provides Reb M produced through extraction from leaves, bioconversion, as well as precision fermentation.
This variety could allow purchasers to weigh expenses, compliance with labels, and local regulations. MANE, on the other hand, merges molecular sourcing with applications and flavor development.
Regulatory frameworks are inconsistent. The FDA provided a no-questions letter for Arzeda’s GRAS submission rather than formal approval. Gerritsen stated that an EFSA review is still underway. PureCircle’s bioconversion process is authorized in both the EU and UK.
Shares of Ingredion were last changing hands at $101.80 on Tuesday, off 74 cents. Core U.S. trading was yet to begin as of the filing time.
Risks: Customers may require more time to convert than indicated by trials. Reb M pricing could decline as more production methods expand. The timeline for European approval is still unclear.
Customer acquisitions and achieved pricing will shape how markets interpret the news. The reported volume is insufficient to impact global sugar balances.
